Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies.

Neurotherapeutics · 2026 · PMC12976507 · PMID 41582064

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0820

boldest claim

The sentences

a strong trendp = 0.050actually significant

In the logistic regression analysis these immunosuppressive treatments demonstrated a strong trend toward successful bridging with OR of 11.2 (95 % CI 1.00–125.7, p = 0.050) ( Fig. 5 ).

also in 5,725 other papers

did not reach statistical significancep = 0.082so close (0.05 < p ≤ 0.1)

Although the overall difference in improvement rates did not reach statistical significance (χ 2 = 9.76, p = 0.082), pairwise comparisons showed significantly lower improvement in ptosis compared to bulbar (p = 0.016) and limb (p = 0.036) symptoms.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.